Haloalkoxy imidazonaphthyridines
US6503923B1 · kind B1 · utility
8Cited by
1References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 3, 2001 |
| Grant date | Jan 7, 2003 |
| Priority date | — |
| Expiry date | Oct 3, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P39/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula I in which R1, R2, R3, R4a, R4b, R5a, R5b, R6 and R7 have the meanings indicated in the specification, and their pharmacologically tolerable salts are useful for preventing and/or treating gastrointestinal diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.